Cy5.5-MALAT1-ASO was predominantly taken by tumors at 48 h post injection and the addition of unlabeled MALAT1 ASO for blocking resulted in a significant decrease in fluorescence intensity in tumor tissues. This evidence concerns the gene MALAT1 and neoplasm.